ACRES Commercial Realty-Cullinan Therapeutics to Present Preclinical Data for CLN-978, a CD19-directed T Cell Engager, at ACR Convergence 2024

Cullinan Therapeutics to Present Preclinical Data for CLN-978, a CD19-directed T Cell Engager, at ACR Convergence 2024

ACRES Commercial Realty(ACR) GlobeNewswire News Room·2024-11-04 20:00